Article info

Download PDFPDF
Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive

Authors

  1. Correspondence to Professor Michael R Ehrenstein, Centre for Rheumatology, UCL, London WC1E 6JF, UK; m.ehrenstein{at}ucl.ac.uk
View Full Text

Citation

Greenwood M, Shipa M, Yeoh S, et al
Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive

Publication history

  • Received April 23, 2020
  • Revised May 15, 2020
  • Accepted May 15, 2020
  • First published May 28, 2020.
Online issue publication 
October 12, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.